Paradoxically Psoriasis, developed in a patient using adalimumab for ankylosing spondylitis: Case report

Basit Öğe Kaydı
dc.contributor.authorİrkin, Sena
dc.contributor.authorÇelik, Neşe Çabuk
dc.contributor.authorKarakaş, Burak
dc.contributor.authorKarataş, Beliz
dc.contributor.authorŞahin, Ali
dc.date.accessioned2025-05-04T16:26:41Z
dc.date.available2025-05-04T16:26:41Z
dc.date.issued2021
dc.departmentSivas Cumhuriyet Üniversitesi
dc.description.abstractAnti-tumor necrosis factor agents are effective drugs for inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease. Although it is indicated for the treatment of Ankylosing Spondylitis, there are recent publications about paradoxical side effects due to these agents, mostly in the form of case reports. In this article, we present the psoriasis case that develops paradoxically in a patient with ankylosing spondylitis using adalimumab.
dc.description.abstract[No abstract available]
dc.identifier.doi10.7197/cmj.842870
dc.identifier.doihttps://doi.org/10.7197/cmj.842870
dc.identifier.endpage181
dc.identifier.issn1305-0028
dc.identifier.issue2
dc.identifier.startpage177
dc.identifier.urihttps://hdl.handle.net/20.500.12418/32842
dc.identifier.volume43
dc.language.isoen
dc.publisherSivas Cumhuriyet University
dc.relation.ispartofCumhuriyet Tıp Dergisi
dc.relation.publicationcategoryRapor
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_DergiPark_20250504
dc.subjectadalimumab
dc.subjectankylosing spondilitis
dc.subjectparadoxal psoriasis
dc.titleParadoxically Psoriasis, developed in a patient using adalimumab for ankylosing spondylitis: Case report
dc.typeCase Report

Dosyalar

Koleksiyon

DergiPark